The drugs are part of a broader class of medicine known as GLP-1s that have grown wildly popular for everything from type 2 diabetes to weight loss and are increasingly seen as having potential benefits far beyond those two conditions
However, differences in trial design and patient backgrounds, such as baseline A1C and concurrent use of metformin, make direct comparisons challenging
In conclusion, our findings underscore the remarkable plasticity of MCs and their ability to shift differentiation states in response to environmental cues, highlighting the importance of ECM molecules in regulating MC behavior
Multi+ is a dietary supplement, not a GLP-1 medication, and it does not replace a varied diet, adequate protein, fiber, fluids, or individualized medical care
The use of GnRH analogs in clinical settings has been complicated because of their short half-life
Retatrutide is a GLP-1, like Wegovy and Zepbound, and a GIP (glucose-dependent insulinotropic polypeptide), like Zepbound, but it also includes a hormone that none of the other weight loss drugs on the market have: glucagon, a hormone produced by the pancreas that raises blood sugar levels to prevent them from dropping too low
